Company Overview and News
Joakim Birgersson har anställts som Senior Vice President Operations med ansvar för koncernens tillverkning och Supply Chain. Han tillträder sin roll, en ny position inom INVISIO, den 1 september 2018 och kommer att ingå i INVISIOs ledningsgrupp.
Joakim Birgersson has been appointed Senior Vice President Operations of INVISIO with responsibility for the Group's Manufacturing and Supply Chain. He will assume his role, a new position within INVISIO, by 1 September 2018, and will be part of the company’s Group Management. Joakim Birgersson has many years of experience within the security and hearing protection industry and has held executive positions in both small and large manufacturing companies, such as Sordin and Peltor.
Investors are always on the lookout for a winning strategy, which is easier said than done. When markets are rattled by widespread global growth concerns, it is difficult for even the most perceptive investors to come up with a foolproof plan. No matter how disciplined and systematic investors are, equity market volatility will always manage to get the better of them. While a few lucky ones rake in the moolah, others fall victim to ad hoc strategies.
HSC MNESP TPB MSA WTW ENVA JOUT
We issued an updated research report on Fortune Brands Home & Security, Inc. (FBHS - Free Report) on Jun 12. This security and safety service provider currently carries a Zacks Rank #3 (Hold). Its market capitalization is approximately $8.4 billion. Let’s delve deeper and discuss the company’s potential growth drivers and possible headwinds. Factors Aiding Fortune Brands Favorable Operating Conditions: We believe that security and safety service provider companies are poised to benefit from the strengthening of U.
MNESP FBHS MSA JCI AAXN
Chicago, IL – June 8, 2018 - Stocks in this week’s article include: Delta Apparel, Inc. (DLA - Free Report) , Turtle Beach Corp. (HEAR - Free Report) , MSA Safety Inc. (MSA - Free Report) and QuinStreet, Inc. (QNST - Free Report) .
TTWO FIX MSA LB QNST UFPI BKNG MNESP MU PATK HEAR DLA PETS
If achieving profit is a company’s goal then having a healthy cash flow is most essential to its existence, development and success. Cash offers the flexibility to make decisions, the means to make investments, the fuel to run its growth engine and can indeed be called the lifeblood of any business.
MNESP HEAR MSA DLA QNST
If achieving profit is a company’s goal then having a healthy cash flow is most essential to its existence, development and success. Cash offers the flexibility to make decisions, the means to make investments, the fuel to run its growth engine and can indeed be called the lifeblood of any business. Often investors flock to companies that earn profits. But even a profit-making company can have a dearth of cash flow and face bankruptcy while meeting its obligations.
MNESP MSA HEAR DLA QNST
2018-09-18 - Asif
Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...
2018-09-18 - Asif
Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...
2018-09-18 - Asif
Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...
Silicon Investor Message Boards
This table lists all message boards related to MSA / MSA Safety Inc. on message board site Silicon Investor.
as of ET